Trial Profile
The Role of 5-alpha Reductase in Mediating Testosterone Actions.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary) ; Testosterone enanthate (Primary) ; Leuprorelin
- Indications Hypogonadism
- Focus Pharmacodynamics
- Acronyms 5aR trial
- 07 Mar 2012 Results published in JAMA: the Journal of the American Medical Association.
- 18 May 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 18 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.